Patent ID: 6624169
Filing Date: 2003-09-23
Classification: A61K,A61P,C07D

Abstract:
A method of treating a urokinase-associated or urokinase receptor-associated disorder in a patient in need of such treatment, comprising administering to the patient a therapeutic amount of a compound of formula I which is present as a racemate or as D- or L-enantiomers and in whichR1 is selected from the group consisting of piperidine and piperazine, wherein said piperidine and said piperazine, independently, are each optionally substituted with C1-C8 alkyl, C1-C3 alkoxy, hydroxy, carboxyl, sulfonyl, nitro, cyano, oxo, halo or a combination thereof, R2 is 2, 4, 6 trisubstituted phenyl, R3 is H or branched or unbranched C1-C4-alkyl, and n is 0 or 1, or a salt of said compound.